Abbott Laboratories (NYSE:ABT) Coverage Initiated at The Goldman Sachs Group
Investment analysts at The Goldman Sachs Group initiated coverage on shares of Abbott Laboratories (NYSE:ABT – Get Free Report) in a report released on Thursday, Marketbeat Ratings reports. The firm set a “buy” rating and a $121.00 price target on the healthcare product maker’s stock. The Goldman Sachs Group’s price objective indicates a potential upside […]
More Stories
Ping An Healthcare and Technology Company Limited (OTCMKTS:PANHF) Sees Large Increase in Short Interest
Ping An Healthcare and Technology Company Limited (OTCMKTS:PANHF – Get Free Report) was the recipient of a large growth in...
Short Interest in NEXON Co., Ltd. (OTCMKTS:NEXOF) Increases By 18.5%
NEXON Co., Ltd. (OTCMKTS:NEXOF – Get Free Report) saw a large growth in short interest in the month of December....
Franklin U.S. Low Volatility High Dividend Index ETF (NASDAQ:LVHD) Plans Dividend of $0.35
Franklin U.S. Low Volatility High Dividend Index ETF (NASDAQ:LVHD – Get Free Report) declared a dividend on Monday, December 30th,NASDAQ...
Regis Resources Limited (OTCMKTS:RGRNF) Sees Significant Growth in Short Interest
Regis Resources Limited (OTCMKTS:RGRNF – Get Free Report) was the recipient of a large growth in short interest in the...
Angel Oak High Yield Opportunities ETF (NASDAQ:AOHY) Raises Dividend to $0.07 Per Share
Angel Oak High Yield Opportunities ETF (NASDAQ:AOHY – Get Free Report) declared a dividend on Monday, December 30th,NASDAQ Dividends reports....
Canada Carbon (CVE:CCB) Trading 100% Higher – Here’s What Happened
Canada Carbon Inc. (CVE:CCB – Get Free Report)’s stock price traded up 100% during mid-day trading on Tuesday . The...